Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Dynamic modeling of chronic myeloid leukemia response to bcr-abl1 tyrosine kinase inhibitors

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-PAA-013
  • By: NOH, Hayeon (College of Pharmacy, Yonsei University, Department of Pharmacy, Incheon, Korea, Republic Of)
  • Co-author(s): Hayeon Noh: Department of Pharmacy, College of Pharmacy, Yonsei University, Incheon, Korea, Republic Of
    Soo-Young Choi: Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic Of
    Hye-Young Song: Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic Of
    Soo-Hyun Kim: Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic Of
    Su Young Jung: Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul, Korea, Republic Of;, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea, Republic Of
    Seungwon Yang: Department of Pharmacy, College of Pharmacy, Yonsei University, Incheon, Korea, Republic Of
    Won-Sik Lee: Department of Internal Medicine, Inje University College of Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic Of
    Hyeong-Joon Kim: Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Korea, Republic Of
    Jee Hyun Kong: Department of Hematology-Oncology, Wonju College of Medicine, Yonsei University, Wonju, Korea, Republic Of
    Hawk Kim: Department of Hematology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea, Republic Of
    Young Rok Do: Division of Hematology-Oncology, Keimyung University, School of Medicine, Keimyung University Hospital, Daegu, Korea, Republic Of
    Jae-Yong Kwak: Division of Hematology-Oncology, Chonbuk National University Medical School, Chonbuk National University Hospital, Jeonju, Korea, Republic Of
    Sukjoong Oh: Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Sungkyunkwan University, Kangbuk Samsung Hospital, Seoul, Korea, Republic Of
    Sung Hyun Kim: Department of Internal Medicine, Dong-A University College of Medicine, Dong-A University Hospital, Busan, Korea, Republic Of
    Jeong-A Kim: Department of Hematology, The Catholic University of Korea, St. Vincent’s Hospital, Suwon, Korea, Republic Of
    Dae Young Zang: Department of Internal Medicine, Hallym University College of Medicine, Hallym University Hospital, Anyang, Korea, Republic Of
    Yeung-Chul Mun: Department of Hematology, School of Medicine, Ewha Womans University, Ewha Womans University Hospital, Seoul, Korea, Republic Of
    Young-Woong Won: Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University College of Medicine, Hanyang University Guri Hospital, Guri, Korea, Republic Of
    Sung-Eun Lee: Department of Hematology, Seoul St. Mary’s Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic Of
    Dong-Wook Kim: Department of Hematology, Seoul St. Mary’s Hospital, Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, Republic Of
    Jangik Lee: Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul, Korea, Republic Of;, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea, Republic Of
  • Abstract:

    Background

    A BCR-ABL1 transcript level at 3 months after the initiation of imatinib has shown to predict the long-term clinical outcomes in patients with chronic myeloid leukemia in chronic phase (CP-CML). The levels obtained earlier than 3 months may also have a similar prognostic significance.

    Purpose

    To assess the value of the BCR-ABL1 transcript..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses